Selbyville, Delaware, July 13, 2021 (GLOBE NEWSWIRE) -- As per the informed views of expert analysts and seasoned forecasters, global lung cancer surgery market, valued USD 5.4 billion in 2020, is projected to register 3.8% CAGR over 2021-2027 and subsequently amass a valuation of USD 7 billion by the end of the stipulated timeframe.
Taking the analysis further, a detailed country-level investigation of the key regions, namely Asia Pacific, Europe, North America, and Latin America is presented in the research document. Moreover, the market is also studied from the perspective of surgical devices and surgical procedures. The research piece also renders a 360-degree outlook of the competitive arena with respect to leading companies, emerging contenders, and new players in this domain.
Growing prevalence of lung cancer across the globe is augmenting the industry growth. In fact, the World Health Organization claims that cancer was the world's second-leading cause of death in 2018. Further, over 10 million fatalities from cancer and 19.3 million new cases were recorded in 2020.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3930302/
Elevated risk factor among the increasing tobacco smoking individuals and booming elderly population base are also enhancing the industry growth. Moreover, technological advancements in cancer therapy, rising inclination towards early cancer detection and treatment, along with positive outlook of the reimbursement scenario are adding considerable momentum to the industry expansion.
On the contrary, high costs associated with diagnosis and surgeries will negatively impact the industry growth in the upcoming years.
Geographical analysis overview:
Asia Pacific, North America, Latin America, and Europe are the top contributors to the overall lung cancer surgery market expansion. Among these regions, North America currently captures majority industry share and will likely record strong gains in the ensuing years. This can be ascribed to increasing technological innovations, and rising frequency of lung cancer in the region.
Asia Pacific market is touted to showcase a remarkable growth rate over the assessment period, attributable to growing tobacco consumption and heightened focus on early diagnosis & treatment of cancer.
Competitive landscape review:
Accuray Inc., AngioDynamics Inc., Ethicon US LLC, Intuitive Surgical Inc., Olympus Corp., Teleflex Inc., Ackermann Instrumente GmbH, Richard Wolf GmbH, Siemens Healthineers AG, and Scanlan International Inc. are the top contenders influencing global lung cancer surgery industry dynamics. These players are increasingly focusing on research & development, partnerships, and investment to improve their market stance.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-lung-cancer-surgery-market-size-research
Global Lung Cancer Surgery Market, by Surgical Devices (Revenue, USD Billion, 2018-2027)
- Monitoring & Visualizing Systems
- Surgical Instruments
- Endosurgical Equipment
Global Lung Cancer Surgery Market, by Surgical Procedures (Revenue, USD Billion, 2018-2027)
- Minimally Invasive Surgeries
- Thoracotomy
Global Lung Cancer Surgery Market Geographical Bifurcation (Revenue, USD Billion, 2018-2027)
North America
- United States
- Canada
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
Asia Pacific
- India
- China
- Japan
- South Korea
- Australia
- Rest of APAC
Latin America
- Mexico
- Brazil
Rest of the World
Global Lung Cancer Surgery Market Competitive Dashboard (Revenue, USD Billion, 2018-2027)
- Richard Wolf GmbH
- Siemens Healthineers AG
- Scanlan International Inc.
- Ackermann Instrumente GmbH
- Teleflex Inc.
- Olympus Corp.
- Intuitive Surgical Inc.
- Ethicon US LLC
- AngioDynamics Inc.
- Accuray Inc.
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Lung Cancer Surgery Market , by Region, 2019-2027 (USD Billion)
1.2.2. Lung Cancer Surgery Market , by Surgical Devices, 2019-2027 (USD Billion)
1.2.3. Lung Cancer Surgery Market , by Surgical Procedures, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Lung Cancer Surgery Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Lung Cancer Surgery Market Dynamics
3.1. Lung Cancer Surgery Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing incidence of lung cancer
3.1.1.2. The growing trend of smoking tobacco
3.1.2. Market Restraint
3.1.2.1. high cost of lung cancer diagnosis & treatments
3.1.3. Market Opportunities
3.1.3.1. Emerging economies
Chapter 4. Global Lung Cancer Surgery Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Lung Cancer Surgery Market , by Surgical Devices
5.1. Market Snapshot
5.2. Global Lung Cancer Surgery Market by Surgical Devices, Performance - Potential Analysis
5.3. Global Lung Cancer Surgery Market Estimates & Forecasts by Surgical Devices 2018-2027 (USD Billion)
5.4. Lung Cancer Surgery Market , Sub Segment Analysis
5.4.1. Surgical Instruments
5.4.2. Monitoring & Visualising Systems
5.4.3. Endosurgical Equipment
Chapter 6. Global Lung Cancer Surgery Market , by Surgical Procedures
6.1. Market Snapshot
6.2. Global Lung Cancer Surgery Market by Surgical Procedures, Performance - Potential Analysis
6.3. Global Lung Cancer Surgery Market Estimates & Forecasts by Surgical Procedures 2018-2027 (USD Billion)
6.4. Lung Cancer Surgery Market , Sub Segment Analysis
6.4.1. Thoracotomy
6.4.2. Minimally Invasive Surgeries
Chapter 7. Global Lung Cancer Surgery Market , Regional Analysis
Related Report:
Global Surgical Robots Market Size study and Regional Forecasts 2021-2027
Global Surgical Robots Market to reach USD 16.92 billion by 2027. Global Surgical Robots Market is valued approximately USD 5.44 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 17.6 % over the forecast period 2021-2027. Robotic surgery is a type of minimally invasive surgery during which doctors use very small surgical instruments that fit into a patient's body through a series of tiny incisions. Also, used for a number of different procedures including Coronary artery bypass, cutting away cancer tissue from sensitive parts of the body such as blood vessels, nerves, or important body organs, gallbladder removal, etc. Demand for minimally invasive surgeries, growing technologies, highly advanced visualization capabilities, rising investment in advance health infrastructure has led the adoption of Surgical Robots Market across the forecast period.
Cancer Diagnostics Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 - 2026
The global cancer diagnostics market share has been depicting a substantial expansion since the last decade or so on account of the increasing cancer prevalence worldwide. Unhealthy diet patterns, sedentary lifestyles including smoking and extensive alcohol consumption, and rising obesity are majorly responsible for the upsurge in the number of cancer cases. According to the American Cancer Society, here will be an anticipated 1.8 million new cancer cases that would be diagnosed in 2020 and 606,520 deaths from cancer, in the United States alone. Latin America is anticipated to emerge as a lucrative growth ground for cancer diagnostics market, driven by the robust prevalence of cancer in the region. Latin America market is anticipated to cross USD 7.3 billion by 2026, with regional governments providing ample funding for research activities to detect new techniques of diagnosis. Also, the healthcare infrastructure in the region has been developed to a great extent, making it a viable avenue for cancer diagnostics business.
The Middle East and Africa region is also coming up as a pivotal revenue pocket for cancer diagnostics industry. Estimates claim that MEA market size was worth USD 856.9 million in 2019 and may depict substantial growth in the years to come.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.